Clinical Trial Update: Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update examining how obesity affects the efficacy of endocrine therapy with aromatase inhibitors in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN